The BioTechniques editorial team talk to Jenny Straiton about her recent Tech News piece on cerebral organoids and the history of neuroscience.
Whilst at the AD/PD™ conference, we had the pleasure of speaking with Patrik Brundin about his talk on novel therapeutic targets for Parkinson’s disease.
In this interview, we spoke with Alysson Muotri about defining cell maturity in brain organoids and how we could address the challenges with these systems.
In this interview, we spoke with Steven Cramer about regenerative stroke therapies, including the challenges involved with bringing these into the clinic.
For International Women’s Day, we spoke with Selina Wray to find out what more could be done to promote gender equality in science, including how we might involve more males in gender inequality discussions.
To mark International Women’s Day, we spoke with Tamara Miller about what more could be done to promote gender equality in science, including any challenges she may have faced as a woman in STEM.
We had the pleasure of speaking with Manmeet Ahluwalia about current vaccine options for glioblastoma, including a survivin vaccine (SurVaxM) for newly diagnosed glioblastoma.
In this video, Marc describes what his favorite aspect in research has been so far and offers advice for those interested in studying CTE.
Take a look behind the scenes of a recent CNS Oncology paper as we ask the authors about the Nativis Voyager® for the treatment of glioblastoma.
In this video, Marc Goldfinger provides us with an overview of his work on CTE and boxer’s brains, including why CTE is of increasing public interest.